The Transcriptomic Landscape of Oncogenic PI3K Reveals Key Functions in Splicing and Gene Expression Regulation
Demographics (1)
- SEX - Biological sex (phv00498036.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00498046.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00498035.v1.p1)
- INHIBITOR - PI3K Inhibitor used (phv00498042.v1.p1)
- IS_TUMOR - Tumor status (phv00498047.v1.p1)
- ON_BIOPSY_SITE - On-treatment biopsy site (phv00498041.v1.p1)
- PIK3CA_MUTATION_ON - PI3K amino acid mutation identified from on biopsy (phv00498044.v1.p1)
- PIK3CA_MUTATION_PRE - PI3K amino acid mutation identified from pre biopsy (phv00498043.v1.p1)
- PRE_BIOPSY_SITE - Pre-treatment biopsy site (phv00498040.v1.p1)
- SAMPLE_ID - Sample ID (phv00498045.v1.p1)
- SAMPLE_ID - Sample ID (phv00498038.v1.p1)
- SUBJECT_ID - Subject ID (phv00498039.v1.p1)
- SUBJECT_ID - Subject ID (phv00498034.v1.p1)
- SUBJECT_ID - Subject ID (phv00498037.v1.p1)